Researchers identify what drives PARP inhibitor resistance in advanced breast cancer 08 May 2024 Researchers at The Institute of Cancer Research, London, have increased our understanding of how a cancer drug called a PARP inhibitor stops working in women with breast cancer that has spread. This research could ultimately help predict who’s more likely to respond to these drugs, and could lead to more effective ways to treat the disease. Find out more Show/Hide
New trial finds radiotherapy combined with hormone therapy can help some advanced prostate cancer patients avoid chemotherapy 08 May 2024 Radiotherapy can be used alongside hormone treatment, delaying the need for chemotherapy and therefore significantly protecting their quality of life for some patients with advanced prostate cancer, according to researchers from The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London. Find out more Show/Hide
Immune cells hunt down cancer around the body – discovery could lead to personalised treatments for advanced breast cancer 02 May 2024 Scientists have discovered the key features of immune B cells which make them successful at targeting tumours – including when cancer has spread to a different part of the body. Find out more Show/Hide
Shape-shifting cancer cell discovery reveals two potential drug targets against skin cancer 17 Apr 2024
Ride announced in memory of Hairy Biker Dave Myers to support The Institute of Cancer Research 15 Apr 2024
Scientists find new ways to convert inhibitors into degraders, paving the way for future drug discoveries 11 Apr 2024
Groundbreaking methodological advance will support the design of innovative new cancer drugs 10 Apr 2024